Ludwig cancer research study shows how novel drug screen can individualize cancer therapy

(Ludwig Institute for Cancer Research) A study conducted by researchers at the Ludwig Center at Harvard has demonstrated how a drug screening method known as dynamic BH3 profiling can be used to quickly identify potentially effective combinations of existing drugs for personalized cancer therapy.